<HTML>
<HEAD>
   <TITLE>k20140701.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">
<a name="page_1"></a><a name="_bclPageBorder1"></a><DIV STYLE="WIDTH: 100%; PADDING-RIGHT: 0%; PADDING-LEFT: 0%">

<a name="_bclHeader1"></a><DIV>


<p style="margin:0in;margin-bottom:.0001pt;"><font face=Calibri,sans-serif lang=EN-US style="font-size:11.0pt;">&nbsp;</font></p>


</DIV>
<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="times new roman" lang=EN-US style="font-size:10.0pt;">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON, D.C. 20549</font></b></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;page-break-after:avoid;text-align:center;"><b><font face="times new roman" lang=EN-US style="font-size:10.0pt;">FORM 8-K</font></b></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;page-break-after:avoid;text-align:center;"><b><font face="times new roman" lang=EN-US style="font-size:10.0pt;">CURRENT REPORT<br>
PURSUANT TO SECTION 13 OR 15(D) OF THE<br>
SECURITIES EXCHANGE ACT 1934</font></b></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;page-break-after:avoid;text-align:center;"><font face="times new roman" lang=EN-US style="font-size:10.0pt;">Date of Report (Date of earliest event
reported): June 27, 2014</font></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;page-break-after:avoid;text-align:center;"><u><font face="times new roman" lang=EN-US style="font-size:10.0pt;">HEALTHCARE CORPORATION OF AMERICA</font></u></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><font face="times new roman" lang=EN-US style="font-size:10.0pt;">(Exact name of
registrant as specified in charter)</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face="times new roman" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center>

<table cellpadding=0 cellspacing=0 border=0 style="border-collapse:collapse;width:732.000000pt;">
 <tr>
  <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">Delaware</font></p>
  </td>
 <td valign=top width=32% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">000-54527</font></p>
  </td>
 <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">27-4563770</font></p>
  </td>
 </tr>
<tr>
  <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:5.4pt;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">(State
  or Other Jurisdiction of Incorporation)</font></p>
  </td>
 <td valign=top width=32% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:5.4pt;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">(Commission
  File Number)</font></p>
  </td>
 <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:5.4pt;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">(IRS
  Employer Identification No.)</font></p>
  </td>
 </tr>
<tr>
  <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:.8pt;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:12.0pt;">&nbsp;</font></p>
  </td>
 <td valign=top width=32% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:.8pt;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:12.0pt;">&nbsp;</font></p>
  </td>
 <td colspan=2 valign=top width=34% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:.8pt;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:12.0pt;">&nbsp;</font></p>
  </td>
 </tr>
<tr>
  <td width=2% style="padding:0in 0in 0in 0in;"><p style="line-height:115%;margin-bottom:10.0pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face=Calibri,sans-serif style="font-size:11.0pt;">&nbsp;</font></p></td>
 <td colspan=3 valign=bottom width=96% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:9.0pt;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">66
  Ford Road, Suite 230<br>
  Denville, NJ, 17834</font></p>
  </td>
 <td width=2% style="padding:0in 0in 0in 0in;"><p style="line-height:115%;margin-bottom:10.0pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face=Calibri,sans-serif style="font-size:11.0pt;">&nbsp;</font></p></td>
 </tr>
<tr>
  <td width=2% style="padding:0in 0in 0in 0in;"><p style="line-height:115%;margin-bottom:10.0pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face=Calibri,sans-serif style="font-size:11.0pt;">&nbsp;</font></p></td>
 <td colspan=3 valign=top width=96% style="padding:0in 0in 0in 0in;">
  <p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:9.0pt;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" style="font-size:10.0pt;">(Address
  of Principal Executive Offices and Zip code)</font></p>
  </td>
 <td width=2% style="padding:0in 0in 0in 0in;"><p style="line-height:115%;margin-bottom:10.0pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face=Calibri,sans-serif style="font-size:11.0pt;">&nbsp;</font></p></td>
 </tr>
<tr height=0>
  <td width=2%>&nbsp;</td>
 <td width=32%>&nbsp;</td>
 <td width=32%>&nbsp;</td>
 <td width=32%>&nbsp;</td>
 <td width=2%>&nbsp;</td>
 </tr>
</table>

</div>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" lang=EN-US style="font-size:10.0pt;">&nbsp;</font></p>

<p align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;"><font face="times new roman" lang=EN-US style="font-size:10.0pt;">Registrant&#8217;s telephone number, including area code:
(973) 983-6300</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;"><font face="times new roman" lang=EN-US style="font-size:10.0pt;">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;"><font face="ms gothic" lang=EN-US style="font-size:10.0pt;">&#9744;</font><font face="times new roman" lang=EN-US style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;"><font face="ms gothic" lang=EN-US style="font-size:10.0pt;">&#9744;</font><font face="times new roman" lang=EN-US style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;"><font face="ms mincho" lang=EN-US style="font-size:10.0pt;">&#9744;</font><font face="times new roman" lang=EN-US style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:12.0pt;"><font face="ms gothic" lang=EN-US style="font-size:10.0pt;">&#9744;</font><font face="times new roman" lang=EN-US style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face="times new roman" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;"><font face="times new roman" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center style="line-height:normal;margin-bottom:.0001pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;">

<hr align=center noshade size=2 width="100%">

&nbsp;</div>

</div><HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always">&nbsp;</div>
&nbsp; <A name="page_2"></A>

<DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<a name="_bclHeader2"></a><DIV>

<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 11pt" lang=EN-US face=Calibri,sans-serif></FONT>&nbsp;</P></DIV><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Item 1.01 Entry Into A Material Definitive Agreement </FONT></B>

<P style="LINE-HEIGHT: 115%; MARGIN: 0in 0in 0pt"><FONT style="LINE-HEIGHT: 115%" face="times new roman"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: 115%; MARGIN: 0in 0in 0pt"><FONT style="LINE-HEIGHT: 115%" face="times new roman"><U><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Modification No. 1 to Amended and Restated Loan and Security Agreement</FONT></U></FONT></P>

<P style="LINE-HEIGHT: 115%; MARGIN: 0in 0in 0pt"><FONT style="LINE-HEIGHT: 115%" face="times new roman"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">As previously <FONT style="FONT-SIZE: 10pt" face="Times New Roman">disclosed by</FONT> Healthcare Corporation of America (the &#8220;Company&#8221;)<FONT style="FONT-SIZE: 10pt" face="Times New Roman">, the Company</FONT>&nbsp;entered into an Amended and Restated Loan and Security Agreement dated May 31, 2014 (the &#8220;PFG Loan&#8221;) with Partners for Growth III, L.P. (&#8220;PFG&#8221;). </FONT></P>

<P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">On June 27, 2014, the Company and its subsidiaries entered into Modification No. 1 to Amended and Restated Loan and Security Agreement (the &#8220;PFG Amendment&#8221;) with PFG. The PFG Amendment amends certain terms of the PFG Loan by providing, in part, that unless the Company elects to pay interest in cash, in whole or in part, the Company shall pay to PFG such interest in kind (&#8220;PIK Interest&#8221;). PIK Interest shall be paid in Common Stock at $0.15 per share; provided, however, if the payment of PIK Interest in the form of Common Stock would cause the Company&#8217;s beneficial ownership limitation as set forth in in the PFG Amendment to be exceeded, then such interest amount shall be paid in cash when due. This Amendment is effective as of June 1, 2014.</FONT></P>

<P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><U><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Amendment Agreement</FONT></U></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">On June 30, 2014, the Company entered into an Amendment Agreement with the holders of the Company&#8217;s 10% Secured Convertible Debentures and Common Stock Purchase Warrants issued pursuant to the Securities Purchase Agreement dated as of May 31, 2014 (the &#8220;SPA&#8221;). </FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Pursuant to the Amendment Agreement, the SPA was amended to reflect that the exempt issuances include the issuance of shares of Common Stock in exchange or upon conversion of principal or interest on the PFG Loan for an effective conversion price of not less than $0.15 per share. Moreover, the maximum subscription amount as defined in the SPA was increased to $7,288,653. Lastly, the Company&#8217;s obligation to file a registration statement with the Securities and Exchange Commission was extended to 120 days, with the corresponding date to achieve effectiveness increased to the 210<SUP>th</SUP> day following the date of the SPA.</FONT></P>

<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Item 9.01 Financial Statements and Exhibits</FONT></B></P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT></B>&nbsp;</P>

<DIV align=left>

<TABLE style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border=0 cellSpacing=0 cellPadding=0>



<TR>

   <TD style="BORDER-BOTTOM: black 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="16%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">Exhibit</FONT></P></TD>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="2%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman"></FONT>&nbsp;</P></TD>

   <TD style="BORDER-BOTTOM: black 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="82%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">Description</FONT></P></TD></TR>

<TR>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="16%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">4.1</FONT></P></TD>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="2%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman"></FONT>&nbsp;</P></TD>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="82%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">Modification No. 1 to Amended and Restated Loan and Security Agreement dated June 27, 2014</FONT></P></TD></TR>

<TR>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="16%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">4.2</FONT></P></TD>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="2%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman"></FONT>&nbsp;</P></TD>

   <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=top width="82%">

   <P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="times new roman">Amendment Agreement to Securities Purchase Agreement dated June 30, 2014</FONT></P></TD></TR></TABLE></DIV>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT></B>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"></FONT></B>&nbsp;</P></DIV>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always">&nbsp;</DIV>

&nbsp; <A name="page_3"></A>

<DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">SIGNATURES</FONT></B></P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 12pt 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 12pt 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HEALTHCARE CORPORATION OF AMERICA</FONT></P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">Dated:&nbsp; July 2, 2014</FONT></P>

<P style="LINE-HEIGHT: normal; MARGIN: 12pt 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; By:&nbsp;&nbsp;&nbsp;</FONT><U><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman">/S/ Natasha Giordano</FONT></U><FONT style="FONT-SIZE: 10pt" lang=EN-US face="times new roman"><BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Name:&nbsp; Natasha Giordano<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Title:&nbsp;&nbsp;&nbsp; Chief Executive Officer</FONT></P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 12pt" lang=EN-US face="times new roman"></FONT>&nbsp;</P>

<P style="LINE-HEIGHT: 115%; MARGIN: 0in 0in 10pt"><FONT style="FONT-SIZE: 11pt" lang=EN-US face=Calibri,sans-serif></FONT>&nbsp;</P></DIV>

</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "k20140701.htm", "secsgml_size_bytes": 25156}]
{"company-data": {"conformed-name": "Healthcare Corp of America", "cik": "0001514682", "assigned-sic": "5912", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54527", "film-number": "14955498"}, "business-address": {"street1": "66 FORD ROAD", "street2": "SUITE 230", "city": "DENVILLE", "state": "NJ", "zip": "07834", "phone": "(973) 983-6300"}, "mail-address": {"street1": "66 FORD ROAD", "street2": "SUITE 230", "city": "DENVILLE", "state": "NJ", "zip": "07834"}, "former-company": {"former-conformed-name": "Selway Capital Acquisition Corp.", "date-changed": "20110307"}}
k20140701.htm - Generated by SEC Publisher for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT 1934
Date of Report (Date of earliest event
reported): June 27, 2014
HEALTHCARE CORPORATION OF AMERICA
(Exact name of
registrant as specified in charter)
Delaware
000-54527
27-4563770
(State
  or Other Jurisdiction of Incorporation)
(Commission
  File Number)
(IRS
  Employer Identification No.)
66
  Ford Road, Suite 230
Denville, NJ, 17834
(Address
  of Principal Executive Offices and Zip code)
Registrant's telephone number, including area code:
(973) 983-6300
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
☐
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 1.01 Entry Into A Material Definitive Agreement
Modification No. 1 to Amended and Restated Loan and Security Agreement
As previously
disclosed by
Healthcare Corporation of America (the "Company")
, the Company
entered into an Amended and Restated Loan and Security Agreement dated May 31, 2014 (the "PFG Loan") with Partners for Growth III, L.P. ("PFG").
On June 27, 2014, the Company and its subsidiaries entered into Modification No. 1 to Amended and Restated Loan and Security Agreement (the "PFG Amendment") with PFG. The PFG Amendment amends certain terms of the PFG Loan by providing, in part, that unless the Company elects to pay interest in cash, in whole or in part, the Company shall pay to PFG such interest in kind ("PIK Interest"). PIK Interest shall be paid in Common Stock at $0.15 per share; provided, however, if the payment of PIK Interest in the form of Common Stock would cause the Company's beneficial ownership limitation as set forth in in the PFG Amendment to be exceeded, then such interest amount shall be paid in cash when due. This Amendment is effective as of June 1, 2014.
Amendment Agreement
On June 30, 2014, the Company entered into an Amendment Agreement with the holders of the Company's 10% Secured Convertible Debentures and Common Stock Purchase Warrants issued pursuant to the Securities Purchase Agreement dated as of May 31, 2014 (the "SPA").
Pursuant to the Amendment Agreement, the SPA was amended to reflect that the exempt issuances include the issuance of shares of Common Stock in exchange or upon conversion of principal or interest on the PFG Loan for an effective conversion price of not less than $0.15 per share. Moreover, the maximum subscription amount as defined in the SPA was increased to $7,288,653. Lastly, the Company's obligation to file a registration statement with the Securities and Exchange Commission was extended to 120 days, with the corresponding date to achieve effectiveness increased to the 210
th
day following the date of the SPA.
Item 9.01 Financial Statements and Exhibits
Exhibit
Description
4.1
Modification No. 1 to Amended and Restated Loan and Security Agreement dated June 27, 2014
4.2
Amendment Agreement to Securities Purchase Agreement dated June 30, 2014
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHCARE CORPORATION OF AMERICA
Dated:  July 2, 2014
By:
/S/ Natasha Giordano
Name:  Natasha Giordano
Title:    Chief Executive Officer